Fact CheckerSign in

NCT03595787Active, not recruiting

COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Feasibility Study of Tripartite Prehabilitation of Patients With Acute Myeloid Leukaemia and High-risk Myelodysplastic Syndromes During Intensive Chemotherapy Before Allogenic Haematopoietic Stem Cell Transplantation: the COHABILIT Protocol

Source: ClinicalTrials.gov · Last updated 18 Dec 2024

Brief summary (registry, in English)

This faisability study aims to evaluate the adhesion of the patient to a multidisciplinary program (adapted physical activity, coaching and nutrition)

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
11 Jul 2018
Start date
4 Apr 2022
Primary completion date
4 May 2025
Lead sponsor
Institut Paoli-Calmettes
NCT number
NCT03595787

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 4 Apr 2022 to the primary completion date, 4 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Performans status 4, unless it is related to the disease

Other

  • Diagnosis of acute promyelocytic Leukemia
  • Palliative treatment
  • Contraindication to moderate physical activity
  • Patient who does not understand French
  • Patient unable to use a smartphone
  • Patient deprived of liberty or placed under the authority of a tutor,
  • Patient considered socially or psychologically unable to comply with the treatment and the required medical follow-up.

Who the study is looking for

  • Diagnosis of acute myeloid leukemia or high-risk myelodysplastic syndrome
  • Age between 18 and 70 years
  • Eligible for an intensive chemotherapy
  • Eligible for allograft
  • Able to answer a questionnaire

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Institut Paoli-Calmettes
Coordinator of this site? Confirm its status
MarseilleFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.